✦ LIBER ✦

Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation

✍ Scribed by Pachnio, A; Dietrich, S; Klapper, W; Humpe, A; Schwake, M; Sedlacek, R; Gramatzki, M; Beck, C

Book ID: 110015039
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 388 KB
Volume: 38
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1705411

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Graft-versus-host disease prophylaxis wi

Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantation

✍ A. H. Filipovich; C. L. Krawczak; J. H. Kersey; P. McGlave; N. K. C. Ramsay; A. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Safe and Efficacious Allogeneic Bone Mar

Safe and Efficacious Allogeneic Bone Marrow Transplantation for Nonmalignant Disorders Using Partial T Cell Depletion and No Posttransplantation Graft-Versus-Host-Disease Prophylaxis

✍ Ronit Elhasid; Myriam Ben Arush; Irena Zaidman; Ronit Leiba; Ayelet Ben Barak; S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Muromonab-CD3 (Orthoclone OKT3®), methyl

Muromonab-CD3 (Orthoclone OKT3®), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation

✍ Benekli, M; Hahn, T; Williams, B T; Cooper, M; Roy, H N; Wallace, P; Stewart, C; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Tacrolimus and methotrexate for the prop

Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies

✍ Uberti, J P; Silver, S M; Adams, P T; Jacobson, P; Scalzo, A; Ratanatharathorn, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 150 KB

Selective depletion of marrow-T cytotoxi

Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation

✍ D. Maraninchi; C. Mawas; D. Guyotat; J. Reiffers; J. P. Vernant; N. Gratecos; J. 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 418 KB

In vitro depletion of mature pan-T lymphocytes has been widely and successfully used to prevent acute graft-versus-host disease (GVHD) after allogeneic bone-marrow transplantation (BMT). However, this procedure has been associated with a high incidence of graft failure and leukemic relapse. In this

Selective depletion of marrow-T cytotoxi

Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation

✍ D. Maraninchi; C. Mawas; D. Guyotat; J. Reiffers; J.P. Vemant; N. Gratecos; J. H 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 331 KB